Chong Ji Y, Vraniak Peter, Etienne Mill, Sherman David, Elkind Mitchell S V
Department of Neurology, Neurological Institute, Columbia University Medical Center, New York, New York, USA.
J Stroke Cerebrovasc Dis. 2005 Jan-Feb;14(1):39-41. doi: 10.1016/j.jstrokecerebrovasdis.2004.09.002.
There are few data available regarding the safety or efficacy of thrombolysis of acute ischemic stroke secondary to myxoma. We present a patient treated with intravenous recombinant tissue plasminogen activator who developed hemorrhage remote from the location of ischemic stroke. Intra-arterial local thrombolysis may be a preferable alternative because of greater risk of hemorrhage from occult tumor emboli or microaneurysms in these patients.
关于黏液瘤继发急性缺血性卒中溶栓治疗的安全性或有效性，目前可用的数据很少。我们报告了一名接受静脉注射重组组织型纤溶酶原激活剂治疗的患者，该患者在远离缺血性卒中部位发生了出血。由于这些患者存在隐匿性肿瘤栓子或微动脉瘤导致出血的风险更高，动脉内局部溶栓可能是一种更可取的替代方法。
Zotero 插件